Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway

Clinical trial NCT00456898 · COMPLETED

Trial details

NCT number: NCT00456898
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major Diabetic Neuropathies Fibromyalgia Vasomotor Symptoms

Start date: 2007-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.